« Previous
Next »
The American Journal of Medicine
Volume 123, Issue 2
, Pages 182.e9-182.e15
, February 2010
Medication Reconciliation and Hypertension Control
References
- . Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005;165:1842–1847
- . The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards. Br J Clin Pharmacol. 2000;49:597–603
- Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health Syst Pharm. 2004;61:1689–1695
- Frequency, type and clinical importance of medication history errors at admission to hospital: a systematic review. CMAJ. 2005;173:510–515
- Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23:1414–1422
- Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med. 2000;160:2129–2134
- Physician response to written feedback on a medication discrepancy found with their elderly ambulatory patients. J Am Geriatr Soc. 2005;53:2173–2177
- Medication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf. 2007;33:750–757
- . Improving medication reconciliation in the outpatient setting. Jt Comm J Qual Patient Saf. 2007;33:286–292
- Implementation of a medication reconciliation process in an ambulatory internal medicine clinic. Qual Saf Health Care. 2007;16:90–94
- . Medication, allergy, and adverse drug event discrepancies in ambulatory care. Fam Med. 2008;40:107–110
- Limited health literacy is a barrier to medication reconciliation in ambulatory care. J Gen Intern Med. 2007;22:1523–1526
- . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162:199–200
- Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–724
Funding: This work was supported by research grants from the Michigan Department of Community Health, Pfizer Pharmaceuticals, Inc., and support from the Health Literacy and Learning Program at Northwestern University and Department of Medicine-Pediatrics, Louisiana State University Health Sciences Center at Shreveport. Dr. Persell was supported by career development award 1 K08 HS015647-01 from the Agency for Healthcare Research and Quality.
Conflict of Interest: Dr. Wolf has received unrestricted research grant funds from Target Corporation and from Pfizer Corporation. No other authors have conflicts of interest. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Authorship: All authors had access to the data and a role in writing the manuscript. Dr. Persell and Dr. Wolf performed the analyses. They take responsibility for the integrity of the data and the accuracy of the data analysis.
PII: S0002-9343(09)00720-7
doi: 10.1016/j.amjmed.2009.06.027
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
The American Journal of Medicine
Volume 123, Issue 2
, Pages 182.e9-182.e15
, February 2010

